WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002032871) COMPOUNDS AND METHODS FOR TREATING MULTIDRUG RESISTANCE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/032871    International Application No.:    PCT/US2001/042691
Publication Date: 25.04.2002 International Filing Date: 12.10.2001
Chapter 2 Demand Filed:    30.04.2002    
IPC:
A61K 9/08 (2006.01), A61K 9/48 (2006.01), C07C 51/06 (2006.01), C07C 211/27 (2006.01), C07C 237/06 (2006.01), C07C 237/24 (2006.01), C07C 271/22 (2006.01), C07D 207/16 (2006.01), C07D 211/58 (2006.01), C07D 211/60 (2006.01), C07D 211/62 (2006.01), C07D 213/30 (2006.01), C07D 213/56 (2006.01), C07D 213/78 (2006.01), C07D 215/20 (2006.01), C07D 215/233 (2006.01), C07D 239/06 (2006.01), C07D 263/06 (2006.01), C07D 263/12 (2006.01), C07D 295/15 (2006.01), C07D 295/185 (2006.01), C07D 295/205 (2006.01), C07D 401/06 (2006.01), C07D 401/12 (2006.01), C07D 401/14 (2006.01), C07D 405/12 (2006.01)
Applicants: THE PROCTER & GAMBLE COMPANY [US/US]; One Procter & Gamble Plaza, Cincinnati, OH 45202 (US)
Inventors: DEGENHARDT, Charles, Raymond; (US).
EICKHOFF, David, Joseph; (US)
Agent: REED, T., David; The Procter & Gamble Company, 5299 Spring Grove Avenue, Cincinnati, OH 45217-1087 (US)
Priority Data:
60/241,127 17.10.2000 US
09/741,588 19.12.2000 US
Title (EN) COMPOUNDS AND METHODS FOR TREATING MULTIDRUG RESISTANCE
(FR) COMPOSES ACYCLIQUES ET METHODES DE TRAITEMENT DE PHARMACORESISTANCE MULTIPLE
Abstract: front page image
(EN)Substituted acyclic compounds are disclosed. The compounds are useful for treating multidrug resistance. The compounds can be formulated in compositions with a carrier and, optionally, a therapeutic agent. One suitable substituted acyclic compound has the formula: (1)
(FR)L'invention concerne des composés acycliques substitués. Ces composés sont utiles pour traiter une pharmacorésistance multiple. Ils peuvent être formulés dans des compositions comprenant un support et, éventuellement, un agent thérapeutique. Un composé acyclique substitué approprié est représenté par la formule: (1)
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)